Improving Tumor Infiltrating Lymphocyte Survival, Function for Melanoma Adoptive T-cell Therapy Through 4-1BB Costimulation

被引：0
|
作者：
Hernandez, Jessica A.
Li, Yufeng
Wang, Yijun
Hwu, Patrick
Radvanyi, Laszlo
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：944 / 944
页数：1
相关论文
共 50 条
  • [21] Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies
    Mamonkin, Maksim
    Mukherjee, Malini
    Srinivasan, Madhuwanti
    Sharma, Sandhya
    Gomes-Silva, Diogo
    Mo, Feiyan
    Krenciute, Giedre
    Orange, Jordan S.
    Brenner, Malcolm K.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (01) : 47 - 58
  • [22] Modulation of cord blood CD8+ T-cell effector differentiation by TGF-β1 and 4-1BB costimulation
    Kim, YJ
    Stringfield, TM
    Chen, Y
    Broxmeyer, HE
    BLOOD, 2005, 105 (01) : 274 - 281
  • [23] Augmenting Efficacy of T-Cell Bispecific Antibodies in AML through a Tumor Stroma-Targeted 4-1BB Agonist
    Haenel, Gerulf
    Neumann, Anne-Sophie
    Pulko, Vesna
    Claus, Christina
    Leutbecher, Alexandra
    Marcinek, Anetta
    Zieger, Nora
    Buecklein, Veit L.
    Umana, Pablo
    Klein, Christian
    Subklewe, Marion
    BLOOD, 2021, 138
  • [24] Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation
    Myers, LM
    Vella, AT
    TRENDS IN IMMUNOLOGY, 2005, 26 (08) : 440 - 446
  • [25] Preclinical pharmacology of MP0310: A 4-1BB/FAP bispecific DARPin drug candidate promoting tumor-restricted T-cell costimulation
    Link, Alexander
    Hepp, Julia
    Reichen, Christian
    Schildknecht, Patricia
    Tosevski, Ivana
    Taylor, Joanna
    Juglair, Laurent
    Titz, Alexander
    Matzner, Mirela
    Bessey, Ralph
    Zitt, Christof
    Lemaillet, Guy
    Herbst, Joerg
    Dawson, Keith M.
    Ji, Hong
    Levitsky, Victor
    Snell, Dan
    Stumpp, Michael T.
    Harstrick, Andreas
    vom Baur, Elmar
    CANCER RESEARCH, 2018, 78 (13)
  • [26] TGF-β-mediated suppression of cytotoxic T lymphocyte (CTL) differentiation can be reversed by 4-1BB costimulation
    Kim, YJ
    Broxmeyer, HE
    FASEB JOURNAL, 2003, 17 (07): : C210 - C210
  • [27] GENOMIC ORGANIZATION AND CHROMOSOMAL LOCALIZATION OF THE T-CELL ANTIGEN 4-1BB
    KWON, BS
    KOZAK, CA
    KIM, KK
    PICKARD, RT
    JOURNAL OF IMMUNOLOGY, 1994, 152 (05): : 2256 - 2262
  • [28] 4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer
    Sakellariou-Thompson, Donastas
    Forget, Marie-Andree
    Creasy, Caitlin
    Bernard, Vincent
    Zhao, Li
    Kim, Young Uk
    Hurd, Mark W.
    Uraoka, Naohiro
    Parra, Edwin Roger
    Kang, Ya'an
    Bristow, Christopher A.
    Rodriguez-Canales, Jaime
    Fleming, Jason B.
    Varadhachary, Gauri
    Javle, Milind
    Overman, Michael J.
    Alvarez, Hector A.
    Heffernan, Timothy P.
    Zhang, Jianhua
    Hwu, Patrick
    Maitra, Anirban
    Haymaker, Cara
    Bernatchez, Chantale
    CLINICAL CANCER RESEARCH, 2017, 23 (23) : 7263 - 7275
  • [29] Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
    Wu, Richard
    Forget, Marie-Andree
    Chacon, Jessica
    Bernatchez, Chantale
    Haymaker, Cara
    Chen, Jie Qing
    Hwu, Patrick
    Radvanyi, Laszlo G.
    CANCER JOURNAL, 2012, 18 (02): : 160 - 175
  • [30] Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation
    Kim, JA
    Averbook, BJ
    Chambers, K
    Rothchild, K
    Kjaergaard, J
    Papay, R
    Shu, SY
    CANCER RESEARCH, 2001, 61 (05) : 2031 - 2037
12345